Akshay S. Desai
Brigham and Women's Hospital(US)Harvard University(US)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Hormonal Regulation and Hypertension, Cardiovascular Function and Risk Factors, Electrolyte and hormonal disorders, Diabetes Treatment and Management
Most-Cited Works
- → Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2024)577 cited
- → Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial(2021)128 cited
- → RNA Interference With Zilebesiran for Mild to Moderate Hypertension(2024)107 cited
- → Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes(2024)101 cited
- → Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial(2024)73 cited
- → Serum Potassium in the PARADIGM-HF Trial(2020)63 cited
- → Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction(2024)28 cited
- → Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome(2025)19 cited
- → Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction(2024)11 cited
- → In‐hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial(2024)9 cited